Neuropsychiatric adverse drug reactions with oral tyrosine kinase inhibitors in metastatic colorectal cancer: an analysis from the FDA Adverse Event Reporting System

INTRODUCTION: New oral tyrosine kinase inhibitors (TKIs) are approved for metastatic colorectal cancer (mCRC). The aim of this study was to assess the neuropsychiatric adverse drug reactions (ADRs) of these drugs reported in the FDA Adverse Event Reporting System (FAERS) database. METHODS: All repor...

Descripción completa

Detalles Bibliográficos
Autores principales: Barbieri, Maria Antonietta, Russo, Giulia, Sorbara, Emanuela Elisa, Cicala, Giuseppe, Franchina, Tindara, Santarpia, Mariacarmela, Speranza, Desirèe, Spina, Edoardo, Silvestris, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646181/
https://www.ncbi.nlm.nih.gov/pubmed/38023143
http://dx.doi.org/10.3389/fonc.2023.1268672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646181/
https://www.ncbi.nlm.nih.gov/pubmed/38023143
http://dx.doi.org/10.3389/fonc.2023.1268672

Ejemplares similares